Vogenx Inc Common Stock Market Cap ($259.82 Million)
Market Cap & Net Worth: Vogenx Inc Common Stock (VOGX)
Vogenx Inc Common Stock market cap. Vogenx Inc Common Stock (NASDAQ:VOGX) has a market capitalization of $259.82 Million ($259.82 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15241 globally and #3630 in its home market, demonstrating a 6.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vogenx Inc Common Stock's stock price $20.25 by its total outstanding shares 14855087 (14.86 Million). Also see cash flow conversion of Vogenx Inc Common Stock for how efficiently the company converts equity into cash flow.
Vogenx Inc Common Stock Market Cap History (2026–2026)
Vogenx Inc Common Stock market cap history from 2026 to 2026. Data shows growth from $300.82 Million to $300.82 Million (0.00% CAGR). Check Vogenx Inc Common Stock stock quote for real-time trading data and today's change.
Vogenx Inc Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vogenx Inc Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VOGX shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VOGX by Market Capitalization
Companies near Vogenx Inc Common Stock in the global market cap rankings as of November 3, 2026. Also see VOGX total asset value for a full breakdown of the balance sheet.
Key companies related to Vogenx Inc Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Vogenx Inc Common Stock (2026–2026)
Market capitalization of Vogenx Inc Common Stock from 2026 to today. Between 2026 and today, Vogenx Inc Common Stock's market cap moved from $300.82 Million to $ 300.82 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $300.82 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of Vogenx Inc Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $259.82 Million USD |
| MoneyControl | $259.82 Million USD |
| MarketWatch | $259.82 Million USD |
| marketcap.company | $259.82 Million USD |
| Reuters | $259.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vogenx Inc Common Stock
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party pay… Read more